Back to Journals » Drug Design, Development and Therapy » Volume 14
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pexidartinib, a Novel Small Molecule CSF-1R Inhibitor in Use for Tenosynovial Giant Cell Tumor: A Systematic Review of Pre-Clinical and Clinical Development
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
20,851 | Dovepress* | 13,507+ | 1,790 | 15,297 | |
PubMed Central* | 7,344 | 1,140 | 8,484 | ||
Totals | 20,851 | 2,930 | 23,781 | ||
*Since 4 May 2020 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
9 | 0 | 0 | 0 | 3 | 6 |
View citations on PubMed Central and Google Scholar